NextGen announces a new strategic collaboration with Doctible
Category: #health  By Pankaj Singh  Date: 2020-01-31
  • share
  • Twitter
  • Facebook
  • LinkedIn

NextGen announces a new strategic collaboration with Doctible

NextGen Healthcare, a renowned electronic health record software developer, reportedly announced its exclusive collaboration with Doctible, a platform that allows healthcare providers to gain real-time feedback from their patients while automating back-office operations.

Doctible enables practices to retain patients and further grow from its comprehensive communications suite. This portfolio helps practices accelerate their online reputation as well as leverage HIPAA compliant texting in order to have more efficient communication.

Doctible platform easily combines with the NextGen Office® cloud-based EHR (Electronic Health Record) and PM (Practice Management) system to support small practices to support growth and increase loyalty.

This platform also gives entirely customizable appointment reminders for the prevention of no-shows and further bring practice into the modern era.

Reputation Management and Smart Reminders and Communication are two of the key components of the suite. Reputation management is useful since, in a world where online reviews are being used to find a perfect healthcare provider, this simple-to-operate platform helps improve a practice’s reputation.

Meanwhile, smart reminders and communication platform ensure that patients get the correct message at the right time to reduce missed appointments.

Chief Executive Officer of Doctible, Ajit Viswanathan stated that the company is thrilled to collaborate with Nextgen Healthcare and its innovative, industry-leading practice management system for small healthcare providers.

Viswanathan further added that this combined experience supports practices with a fully-automated platform that would help to grow patient loyalty while minimizing no-shows.

Executive Vice President and Chief Solutions Officer of NextGen Healthcare, John S. Beck stated that while the company is increasingly innovating organically, collaborations would be a quick and economical ways to extend capabilities to benefit the company’s clients.

Beck further added that the new partnership with Doctible would allow small practices using NextGen Office to bring in growth while offering enhanced care for its patients.

Recently, in December 2019, NextGen Healthcare completed the acquisition of Otto Health, to take it further in its mission of facilitating clients integrated capabilities that further delight and engage the patients.

 

Source credit: https://www.nextgen.com/-/media/files/press-releases/18696.pdf

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With an experience as an insurance underwriter and a freelance writer under his belt, Pankaj Singh boasts of quite some expertise in the field of content creation. A qualified Post Graduate in Management, Pankaj has also completed a detailed course in Digital Marketin...

Read More

More News By Pankaj Singh

Toyota and ENEOS team up to develop hydrogen fuel-cell system in Japan
Toyota and ENEOS team up to develop hydrogen fuel-cell system in Japan
By Pankaj Singh

Japanese automotive giant, Toyota has reportedly tapped Japanese oil & energy corporation, ENEOS, to explore the field of hydrogen-based power to help with the development of a hydrogen fuel-cell system that would power Woven City, Japan’s ...

KPI Global secures 12.5 MW captive solar project from Anupam Rasayan
KPI Global secures 12.5 MW captive solar project from Anupam Rasayan
By Pankaj Singh

Gujarats leading solar power generating company, KPI Global, has recently announced receiving an order for building a 12.5 megawatts solar project under the captive power producer capacity from Surat-headquartered Anupam Rasayan India. It has been r...

Adverum Biotechnologies announces new data from OPTIC Phase 1 trial
Adverum Biotechnologies announces new data from OPTIC Phase 1 trial
By Pankaj Singh

Adverum Biotechnologies, a California based biotech company, has reportedly announced new clinical data from the OPTIC Phase 1 with dose ranging clinical stage trial of gene therapy intravitreal injection namely ADVM-022. The OPTIC trial has enrolle...